Cross Shawn bought PCRX
April 20, 2026 · Form 4 insider transaction
Cross Shawn bought 7,714 shares of Pacira BioSciences, Inc. at $16.45 per share, a transaction worth $126.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,714
Price
$16.45
Total value
$126.9K
InsiderCross Shawn
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 20, 2026
Filing dateApril 22, 2026
Shares owned after113,055
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025.